ABCG2 expression is notably elevated in the side population (SP) of stem-like cells, which exhibit enhanced drug resistance compared to non-stem-like cancer cells, highlighting its importance in maintaining the chemoresistant phenotype of CSCs101. This evidence concerns the gene ABCG2 and cancer.